Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,954,233 11.120% | 642,472 (+6.90%) | Filing History |
| 2024-02-08 10:14 am Purchase | 2023-12-29 | 13G | Myriad Genetics, Inc. MYGN | Wellington Management Group LLP | 7,219,706 8.070% | 432,483 (+6.37%) | Filing History |
| 2024-01-24 1:20 pm Sale | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | STATE STREET CORP STT | 4,700,631 5.250% | -319,792 (-6.37%) | Filing History |
| 2024-01-23 4:31 pm Sale | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 3,561,337 4.000% | -699,704 (-16.42%) | Filing History |
| 2024-01-22 2:03 pm Purchase | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,658,349 16.600% | 302,250 (+2.11%) | Filing History |
| 2023-10-17 4:14 pm Purchase | 2023-10-10 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,261,041 5.200% | 4,261,041 (New Position) | Filing History |
| 2023-03-01 4:10 pm Purchase | 2023-02-24 | 13G | Myriad Genetics, Inc. MYGN | GLENVIEW CAPITAL MANAGEMENT, LLC | 4,312,131 5.310% | 4,312,131 (New Position) | Filing History |
| 2023-02-14 08:46 am Purchase | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,000,000 8.640% | 2,300,000 (+48.94%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,311,761 11.490% | 162,240 (+1.77%) | Filing History |
| 2023-02-06 2:53 pm Purchase | 2022-12-30 | 13G | Myriad Genetics, Inc. MYGN | Wellington Management Group LLP | 6,787,223 8.380% | 2,461,448 (+56.90%) | Filing History |
| 2023-01-31 09:19 am Purchase | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | STATE STREET CORP STT | 5,020,423 6.200% | 610,020 (+13.83%) | Filing History |
| 2023-01-23 3:52 pm Sale | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,356,099 17.700% | -328,688 (-2.24%) | Filing History |
| 2023-01-09 5:09 pm Sale | 2022-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 3,304,456 4.100% | -3,011,909 (-47.68%) | Filing History |
| 2022-05-12 4:06 pm Purchase | 2022-05-02 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 4,700,000 5.850% | 1,950,000 (+70.91%) | Filing History |
| 2022-02-14 09:39 am Sale | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 2,750,000 3.440% | -2,250,000 (-45.00%) | Filing History |
| 2022-02-11 3:19 pm Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | STATE STREET CORP STT | 4,410,403 5.520% | 694,873 (+18.70%) | Filing History |
| 2022-02-10 5:37 pm Sale | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | EARNEST PARTNERS LLC | 6,316,365 7.900% | -415,064 (-6.17%) | Filing History |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,149,521 11.460% | 852,657 (+10.28%) | Filing History |
| 2022-02-04 09:21 am Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | Wellington Management Group LLP | 4,325,775 5.420% | 952,575 (+28.24%) | Filing History |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,684,787 18.400% | 0 (Unchanged) | Filing History |